↓ Skip to main content

Cochrane Database of Systematic Reviews

Bisphosphonates for advanced prostate cancer

Overview of attention for article published in Cochrane database of systematic reviews, October 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
2 policy sources
twitter
1 tweeter

Citations

dimensions_citation
117 Dimensions

Readers on

mendeley
113 Mendeley
connotea
1 Connotea
Title
Bisphosphonates for advanced prostate cancer
Published in
Cochrane database of systematic reviews, October 2006
DOI 10.1002/14651858.cd006250
Pubmed ID
Authors

Kwok Keung Yuen, Mike Shelley, Wai Man Sze, Timothy J. Wilt, Malcolm Mason

Abstract

Prostate cancer is the most common cancer in men in many western countries. It is characterized by its propensity for bone metastases which occur in more than 80% of patients with advanced disease. Patients are at risk of complications including pain, hypercalcaemia, bone fracture and spinal cord compression. Hormonal treatment is the mainstay of treatment for these patients but most of them will then become hormone refractory. Bisphosphonates act by inhibiting osteoclast activities and are a potential therapeutic option for metastatic prostate cancer. In addition, they have been shown to reduce pain in patients with bone metastases as a consequence of multiple myeloma. Early uncontrolled studies of bisphosphonates in metastatic prostate cancer patients have shown encouraging results.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Hong Kong 1 <1%
Netherlands 1 <1%
Canada 1 <1%
Unknown 109 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 17%
Student > Master 18 16%
Student > Bachelor 14 12%
Other 13 12%
Student > Postgraduate 11 10%
Other 25 22%
Unknown 13 12%
Readers by discipline Count As %
Medicine and Dentistry 69 61%
Agricultural and Biological Sciences 6 5%
Psychology 5 4%
Nursing and Health Professions 5 4%
Engineering 2 2%
Other 8 7%
Unknown 18 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2021.
All research outputs
#3,501,107
of 17,944,974 outputs
Outputs from Cochrane database of systematic reviews
#6,086
of 11,788 outputs
Outputs of similar age
#38,615
of 198,954 outputs
Outputs of similar age from Cochrane database of systematic reviews
#113
of 204 outputs
Altmetric has tracked 17,944,974 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,788 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.4. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,954 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.